aluates Reports

$ 0.0

Automative

Global Urate-stimulating Excretion Agents Market Research Report 2024

Published Date: August 2024

Report Code: QYRE-Auto-9G18172

BUY CHAPTERS

Global Urate-stimulating Excretion Agents Market Research Report 2024

Code: QYRE-Auto-9G18172

Report

August 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Fuji yakuhin

Lannett Company

TEVA

Eisai Co Ltd

Astrazeneca plc

Towa Pharmaceutical

Excella Gmbh

Urate-stimulating Excretion Agents Market

Urate-stimulating excretion agents are a class of medications designed to lower blood uric acid levels by enhancing its elimination from the body.They work by inhibiting the reabsorption of uric acid in the kidneys,which increases its excretion in the urine.These agents are used primarily in the treatment of chronic gout and hyperuricemia.

The global Urate-stimulating Excretion Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Urate-stimulating Excretion Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Urate-stimulating Excretion Agents is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global manufacturers of Urate-stimulating Excretion Agents include Fuji Yakuhin, Lannett Company, Teva, Eisai, AstraZeneca, Towa Pharmaceutical, Excella, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Urate-stimulating Excretion Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urate-stimulating Excretion Agents.

The Urate-stimulating Excretion Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Urate-stimulating Excretion Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Urate-stimulating Excretion Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Urate-stimulating Excretion Agents Market Report

Report Metric	Details
Report Name	Urate-stimulating Excretion Agents Market
Segment by Type	Benzbromarone Lesinurad Dotinurad Probenecid Other
Segment by Application	Hospitals and Clinics Retail Pharmacies Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Fuji Yakuhin, Lannett Company, Teva, Eisai, AstraZeneca, Towa Pharmaceutical, Excella
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Urate-stimulating Excretion Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Urate-stimulating Excretion Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Urate-stimulating Excretion Agents Market report?

Ans: The main players in the Urate-stimulating Excretion Agents Market are Fuji Yakuhin, Lannett Company, Teva, Eisai, AstraZeneca, Towa Pharmaceutical, Excella

What are the Application segmentation covered in the Urate-stimulating Excretion Agents Market report?

Ans: The Applications covered in the Urate-stimulating Excretion Agents Market report are Hospitals and Clinics, Retail Pharmacies, Other

What are the Type segmentation covered in the Urate-stimulating Excretion Agents Market report?

Ans: The Types covered in the Urate-stimulating Excretion Agents Market report are Benzbromarone, Lesinurad, Dotinurad, Probenecid, Other

Recommended Reports

Uric Acid Disorders

Renal & Urinary Devices

Bladder & Urethra Treatment

1 Urate-stimulating Excretion Agents Market Overview

1.1 Product Definition

1.2 Urate-stimulating Excretion Agents by Type

1.2.1 Global Urate-stimulating Excretion Agents Market Value Comparison by Type (2024-2030)

1.2.2 Benzbromarone

1.2.3 Lesinurad

1.2.4 Dotinurad

1.2.5 Probenecid

1.2.6 Other

1.3 Urate-stimulating Excretion Agents by Application

1.3.1 Global Urate-stimulating Excretion Agents Market Value by Application (2024-2030)

1.3.2 Hospitals and Clinics

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Global Urate-stimulating Excretion Agents Market Size Estimates and Forecasts

1.4.1 Global Urate-stimulating Excretion Agents Revenue 2019-2030

1.4.2 Global Urate-stimulating Excretion Agents Sales 2019-2030

1.4.3 Global Urate-stimulating Excretion Agents Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Urate-stimulating Excretion Agents Market Competition by Manufacturers

2.1 Global Urate-stimulating Excretion Agents Sales Market Share by Manufacturers (2019-2024)

2.2 Global Urate-stimulating Excretion Agents Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Urate-stimulating Excretion Agents Average Price by Manufacturers (2019-2024)

2.4 Global Key Players of Urate-stimulating Excretion Agents, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Urate-stimulating Excretion Agents, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Urate-stimulating Excretion Agents, Product Type & Application

2.7 Global Key Manufacturers of Urate-stimulating Excretion Agents, Date of Enter into This Industry

2.8 Global Urate-stimulating Excretion Agents Market Competitive Situation and Trends

2.8.1 Global Urate-stimulating Excretion Agents Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Urate-stimulating Excretion Agents Players Market Share by Revenue

2.8.3 Global Urate-stimulating Excretion Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Urate-stimulating Excretion Agents Market Scenario by Region

3.1 Global Urate-stimulating Excretion Agents Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Urate-stimulating Excretion Agents Sales by Region: 2019-2030

3.2.1 Global Urate-stimulating Excretion Agents Sales by Region: 2019-2024

3.2.2 Global Urate-stimulating Excretion Agents Sales by Region: 2025-2030

3.3 Global Urate-stimulating Excretion Agents Revenue by Region: 2019-2030

3.3.1 Global Urate-stimulating Excretion Agents Revenue by Region: 2019-2024

3.3.2 Global Urate-stimulating Excretion Agents Revenue by Region: 2025-2030

3.4 North America Urate-stimulating Excretion Agents Market Facts & Figures by Country

3.4.1 North America Urate-stimulating Excretion Agents Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Urate-stimulating Excretion Agents Sales by Country (2019-2030)

3.4.3 North America Urate-stimulating Excretion Agents Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Urate-stimulating Excretion Agents Market Facts & Figures by Country

3.5.1 Europe Urate-stimulating Excretion Agents Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Urate-stimulating Excretion Agents Sales by Country (2019-2030)

3.5.3 Europe Urate-stimulating Excretion Agents Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Urate-stimulating Excretion Agents Market Facts & Figures by Region

3.6.1 Asia Pacific Urate-stimulating Excretion Agents Market Size by Region: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Urate-stimulating Excretion Agents Sales by Region (2019-2030)

3.6.3 Asia Pacific Urate-stimulating Excretion Agents Revenue by Region (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Urate-stimulating Excretion Agents Market Facts & Figures by Country

3.7.1 Latin America Urate-stimulating Excretion Agents Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Urate-stimulating Excretion Agents Sales by Country (2019-2030)

3.7.3 Latin America Urate-stimulating Excretion Agents Revenue by Country

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Urate-stimulating Excretion Agents Market Facts & Figures by Country

3.8.1 Middle East and Africa Urate-stimulating Excretion Agents Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Urate-stimulating Excretion Agents Sales by Country (2019-2030)

3.8.3 Middle East and Africa Urate-stimulating Excretion Agents Revenue by Country

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Urate-stimulating Excretion Agents Sales by Type (2019-2030)

4.1.1 Global Urate-stimulating Excretion Agents Sales by Type (2019-2024)

4.1.2 Global Urate-stimulating Excretion Agents Sales by Type (2025-2030)

4.1.3 Global Urate-stimulating Excretion Agents Sales Market Share by Type (2019-2030)

4.2 Global Urate-stimulating Excretion Agents Revenue by Type (2019-2030)

4.2.1 Global Urate-stimulating Excretion Agents Revenue by Type (2019-2024)

4.2.2 Global Urate-stimulating Excretion Agents Revenue by Type (2025-2030)

4.2.3 Global Urate-stimulating Excretion Agents Revenue Market Share by Type (2019-2030)

4.3 Global Urate-stimulating Excretion Agents Price by Type (2019-2030)

5 Segment by Application

5.1 Global Urate-stimulating Excretion Agents Sales by Application (2019-2030)

5.1.1 Global Urate-stimulating Excretion Agents Sales by Application (2019-2024)

5.1.2 Global Urate-stimulating Excretion Agents Sales by Application (2025-2030)

5.1.3 Global Urate-stimulating Excretion Agents Sales Market Share by Application (2019-2030)

5.2 Global Urate-stimulating Excretion Agents Revenue by Application (2019-2030)

5.2.1 Global Urate-stimulating Excretion Agents Revenue by Application (2019-2024)

5.2.2 Global Urate-stimulating Excretion Agents Revenue by Application (2025-2030)

5.2.3 Global Urate-stimulating Excretion Agents Revenue Market Share by Application (2019-2030)

5.3 Global Urate-stimulating Excretion Agents Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Fuji Yakuhin

6.1.1 Fuji Yakuhin Company Information

6.1.2 Fuji Yakuhin Description and Business Overview

6.1.3 Fuji Yakuhin Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Fuji Yakuhin Urate-stimulating Excretion Agents Product Portfolio

6.1.5 Fuji Yakuhin Recent Developments/Updates

6.2 Lannett Company

6.2.1 Lannett Company Company Information

6.2.2 Lannett Company Description and Business Overview

6.2.3 Lannett Company Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Lannett Company Urate-stimulating Excretion Agents Product Portfolio

6.2.5 Lannett Company Recent Developments/Updates

6.3 Teva

6.3.1 Teva Company Information

6.3.2 Teva Description and Business Overview

6.3.3 Teva Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Teva Urate-stimulating Excretion Agents Product Portfolio

6.3.5 Teva Recent Developments/Updates

6.4 Eisai

6.4.1 Eisai Company Information

6.4.2 Eisai Description and Business Overview

6.4.3 Eisai Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Eisai Urate-stimulating Excretion Agents Product Portfolio

6.4.5 Eisai Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Company Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.5.4 AstraZeneca Urate-stimulating Excretion Agents Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Towa Pharmaceutical

6.6.1 Towa Pharmaceutical Company Information

6.6.2 Towa Pharmaceutical Description and Business Overview

6.6.3 Towa Pharmaceutical Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Towa Pharmaceutical Urate-stimulating Excretion Agents Product Portfolio

6.6.5 Towa Pharmaceutical Recent Developments/Updates

6.7 Excella

6.7.1 Excella Company Information

6.7.2 Excella Description and Business Overview

6.7.3 Excella Urate-stimulating Excretion Agents Sales, Revenue and Gross Margin (2019-2024)

6.7.4 Excella Urate-stimulating Excretion Agents Product Portfolio

6.7.5 Excella Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Urate-stimulating Excretion Agents Industry Chain Analysis

7.2 Urate-stimulating Excretion Agents Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Urate-stimulating Excretion Agents Production Mode & Process

7.4 Urate-stimulating Excretion Agents Sales and Marketing

7.4.1 Urate-stimulating Excretion Agents Sales Channels

7.4.2 Urate-stimulating Excretion Agents Distributors

7.5 Urate-stimulating Excretion Agents Customers

8 Urate-stimulating Excretion Agents Market Dynamics

8.1 Urate-stimulating Excretion Agents Industry Trends

8.2 Urate-stimulating Excretion Agents Market Drivers

8.3 Urate-stimulating Excretion Agents Market Challenges

8.4 Urate-stimulating Excretion Agents Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Fuji yakuhin

Lannett Company

TEVA

Eisai Co Ltd

Astrazeneca plc

Towa Pharmaceutical

Excella Gmbh

List of Tables

Table 1. Global Urate-stimulating Excretion Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Urate-stimulating Excretion Agents Market Value by Application (2024-2030) & (US$ Million)

Table 3. Global Urate-stimulating Excretion Agents Market Competitive Situation by Manufacturers in 2023

Table 4. Global Urate-stimulating Excretion Agents Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Urate-stimulating Excretion Agents Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Urate-stimulating Excretion Agents Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Urate-stimulating Excretion Agents Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Urate-stimulating Excretion Agents Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Urate-stimulating Excretion Agents, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Urate-stimulating Excretion Agents, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Urate-stimulating Excretion Agents, Product Type & Application

Table 12. Global Key Manufacturers of Urate-stimulating Excretion Agents, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Urate-stimulating Excretion Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urate-stimulating Excretion Agents as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Urate-stimulating Excretion Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Urate-stimulating Excretion Agents Sales by Region (2019-2024) & (K Units)

Table 18. Global Urate-stimulating Excretion Agents Sales Market Share by Region (2019-2024)

Table 19. Global Urate-stimulating Excretion Agents Sales by Region (2025-2030) & (K Units)

Table 20. Global Urate-stimulating Excretion Agents Sales Market Share by Region (2025-2030)

Table 21. Global Urate-stimulating Excretion Agents Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Urate-stimulating Excretion Agents Revenue Market Share by Region (2019-2024)

Table 23. Global Urate-stimulating Excretion Agents Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Urate-stimulating Excretion Agents Revenue Market Share by Region (2025-2030)

Table 25. North America Urate-stimulating Excretion Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Urate-stimulating Excretion Agents Sales by Country (2019-2024) & (K Units)

Table 27. North America Urate-stimulating Excretion Agents Sales by Country (2025-2030) & (K Units)

Table 28. North America Urate-stimulating Excretion Agents Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Urate-stimulating Excretion Agents Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Urate-stimulating Excretion Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Urate-stimulating Excretion Agents Sales by Country (2019-2024) & (K Units)

Table 32. Europe Urate-stimulating Excretion Agents Sales by Country (2025-2030) & (K Units)

Table 33. Europe Urate-stimulating Excretion Agents Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Urate-stimulating Excretion Agents Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Urate-stimulating Excretion Agents Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Urate-stimulating Excretion Agents Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Urate-stimulating Excretion Agents Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Urate-stimulating Excretion Agents Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Urate-stimulating Excretion Agents Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Urate-stimulating Excretion Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Urate-stimulating Excretion Agents Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Urate-stimulating Excretion Agents Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Urate-stimulating Excretion Agents Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Urate-stimulating Excretion Agents Revenue Market Share by Country (2019-2024)

Table 45. Middle East and Africa Urate-stimulating Excretion Agents Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East and Africa Urate-stimulating Excretion Agents Sales by Country (2019-2024) & (K Units)

Table 47. Middle East and Africa Urate-stimulating Excretion Agents Sales by Country (2025-2030) & (K Units)

Table 48. Middle East and Africa Urate-stimulating Excretion Agents Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East and Africa Urate-stimulating Excretion Agents Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Urate-stimulating Excretion Agents Sales (K Units) by Type (2019-2024)

Table 51. Global Urate-stimulating Excretion Agents Sales (K Units) by Type (2025-2030)

Table 52. Global Urate-stimulating Excretion Agents Sales Market Share by Type (2019-2024)

Table 53. Global Urate-stimulating Excretion Agents Sales Market Share by Type (2025-2030)

Table 54. Global Urate-stimulating Excretion Agents Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Urate-stimulating Excretion Agents Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Urate-stimulating Excretion Agents Revenue Market Share by Type (2019-2024)

Table 57. Global Urate-stimulating Excretion Agents Revenue Market Share by Type (2025-2030)

Table 58. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Type (2019-2024)

Table 59. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Type (2025-2030)

Table 60. Global Urate-stimulating Excretion Agents Sales (K Units) by Application (2019-2024)

Table 61. Global Urate-stimulating Excretion Agents Sales (K Units) by Application (2025-2030)

Table 62. Global Urate-stimulating Excretion Agents Sales Market Share by Application (2019-2024)

Table 63. Global Urate-stimulating Excretion Agents Sales Market Share by Application (2025-2030)

Table 64. Global Urate-stimulating Excretion Agents Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Urate-stimulating Excretion Agents Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Urate-stimulating Excretion Agents Revenue Market Share by Application (2019-2024)

Table 67. Global Urate-stimulating Excretion Agents Revenue Market Share by Application (2025-2030)

Table 68. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Application (2019-2024)

Table 69. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Application (2025-2030)

Table 70. Fuji Yakuhin Company Information

Table 71. Fuji Yakuhin Description and Business Overview

Table 72. Fuji Yakuhin Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Fuji Yakuhin Urate-stimulating Excretion Agents Product

Table 74. Fuji Yakuhin Recent Developments/Updates

Table 75. Lannett Company Company Information

Table 76. Lannett Company Description and Business Overview

Table 77. Lannett Company Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Lannett Company Urate-stimulating Excretion Agents Product

Table 79. Lannett Company Recent Developments/Updates

Table 80. Teva Company Information

Table 81. Teva Description and Business Overview

Table 82. Teva Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Teva Urate-stimulating Excretion Agents Product

Table 84. Teva Recent Developments/Updates

Table 85. Eisai Company Information

Table 86. Eisai Description and Business Overview

Table 87. Eisai Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Eisai Urate-stimulating Excretion Agents Product

Table 89. Eisai Recent Developments/Updates

Table 90. AstraZeneca Company Information

Table 91. AstraZeneca Description and Business Overview

Table 92. AstraZeneca Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. AstraZeneca Urate-stimulating Excretion Agents Product

Table 94. AstraZeneca Recent Developments/Updates

Table 95. Towa Pharmaceutical Company Information

Table 96. Towa Pharmaceutical Description and Business Overview

Table 97. Towa Pharmaceutical Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Towa Pharmaceutical Urate-stimulating Excretion Agents Product

Table 99. Towa Pharmaceutical Recent Developments/Updates

Table 100. Excella Company Information

Table 101. Excella Description and Business Overview

Table 102. Excella Urate-stimulating Excretion Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Excella Urate-stimulating Excretion Agents Product

Table 104. Excella Recent Developments/Updates

Table 105. Key Raw Materials Lists

Table 106. Raw Materials Key Suppliers Lists

Table 107. Urate-stimulating Excretion Agents Distributors List

Table 108. Urate-stimulating Excretion Agents Customers List

Table 109. Urate-stimulating Excretion Agents Market Trends

Table 110. Urate-stimulating Excretion Agents Market Drivers

Table 111. Urate-stimulating Excretion Agents Market Challenges

Table 112. Urate-stimulating Excretion Agents Market Restraints

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Product Picture of Urate-stimulating Excretion Agents

Figure 2. Global Urate-stimulating Excretion Agents Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Urate-stimulating Excretion Agents Market Share by Type: 2023 & 2030

Figure 4. Benzbromarone Product Picture

Figure 5. Lesinurad Product Picture

Figure 6. Dotinurad Product Picture

Figure 7. Probenecid Product Picture

Figure 8. Other Product Picture

Figure 9. Global Urate-stimulating Excretion Agents Market Value by Application (2024-2030) & (US$ Million)

Figure 10. Global Urate-stimulating Excretion Agents Market Share by Application: 2023 & 2030

Figure 11. Hospitals and Clinics

Figure 12. Retail Pharmacies

Figure 13. Other

Figure 14. Global Urate-stimulating Excretion Agents Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Urate-stimulating Excretion Agents Market Size (2019-2030) & (US$ Million)

Figure 16. Global Urate-stimulating Excretion Agents Sales (2019-2030) & (K Units)

Figure 17. Global Urate-stimulating Excretion Agents Average Price (US$/Unit) & (2019-2030)

Figure 18. Urate-stimulating Excretion Agents Report Years Considered

Figure 19. Urate-stimulating Excretion Agents Sales Share by Manufacturers in 2023

Figure 20. Global Urate-stimulating Excretion Agents Revenue Share by Manufacturers in 2023

Figure 21. Global 5 and 10 Largest Urate-stimulating Excretion Agents Players: Market Share by Revenue in Urate-stimulating Excretion Agents in 2023

Figure 22. Urate-stimulating Excretion Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 23. Global Urate-stimulating Excretion Agents Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 24. North America Urate-stimulating Excretion Agents Sales Market Share by Country (2019-2030)

Figure 25. North America Urate-stimulating Excretion Agents Revenue Market Share by Country (2019-2030)

Figure 26. United States Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Canada Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 28. Europe Urate-stimulating Excretion Agents Sales Market Share by Country (2019-2030)

Figure 29. Europe Urate-stimulating Excretion Agents Revenue Market Share by Country (2019-2030)

Figure 30. Germany Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. France Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. U.K. Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Italy Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Russia Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 35. Asia Pacific Urate-stimulating Excretion Agents Sales Market Share by Region (2019-2030)

Figure 36. Asia Pacific Urate-stimulating Excretion Agents Revenue Market Share by Region (2019-2030)

Figure 37. China Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. Japan Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. South Korea Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. India Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Australia Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. China Taiwan Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Southeast Asia Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Urate-stimulating Excretion Agents Sales Market Share by Country (2019-2030)

Figure 45. Mexico Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 46. Brazil Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Argentina Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Colombia Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East and Africa Urate-stimulating Excretion Agents Sales Market Share by Country (2019-2030)

Figure 50. Middle East and Africa Urate-stimulating Excretion Agents Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Urate-stimulating Excretion Agents Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Urate-stimulating Excretion Agents by Type (2019-2030)

Figure 55. Global Revenue Market Share of Urate-stimulating Excretion Agents by Type (2019-2030)

Figure 56. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Urate-stimulating Excretion Agents by Application (2019-2030)

Figure 58. Global Revenue Market Share of Urate-stimulating Excretion Agents by Application (2019-2030)

Figure 59. Global Urate-stimulating Excretion Agents Price (US$/Unit) by Application (2019-2030)

Figure 60. Urate-stimulating Excretion Agents Value Chain

Figure 61. Urate-stimulating Excretion Agents Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drugs for Treating Hyperuricemia Market Research Report 2024

Global Uric Acid Production Inhibitors Market Research Report 2024

Global Dotinurad Tablets Market Research Report 2024

Global Uric Acid Analyzer Market Research Report 2024

Global Probenecid Tablets Market Research Report 2024

Global Xanthine Oxidase Inhibitors for the Treatment of Hyperuricemia Market Research Report 2024

Antihyperuricemic Agents Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Uric Acid Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hyperuricemia Micromolecular Drugs Market Research Report 2024

Global Chronic Gout Treatment Drug Market Research Report 2024

Uric Acid Health Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Benzbromarone Tablets Market Research Report 2024

Global Uric Acid Meter Market Research Report 2025

Global Topiroxostat Tablets Market Research Report 2024

Global Febuxostat API Market Research Report 2024

Global Ursodeoxycholic Acid Drug Market Research Report 2024

Drugs of Ursodeoxycholic Acid Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Urinary pH Modifiers Market Research Report 2024

Global Drugs for the Treatment of Refractory Gout Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions